LANDINI, IDA

LANDINI, IDA  

Scienze della Salute (DSS)  

Mostra records
Risultati 1 - 20 di 62 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy 2022 Enrico Mini, Ida Landini, Antonello Di Paolo, Gloria Ravegnini, Simona Saponara, Maria Frosini, Andrea Lapucci, Stefania Nobili
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 2018 Magherini, Francesca; Fiaschi, Tania; Valocchia, Elisa; Becatti, Matteo; Pratesi, Alessandro; Marzo, Tiziano; Massai, Lara; Gabbiani, Chiara; Landini, Ida; Nobili, Stefania; Mini, Enrico; Messori, Luigi; Modesti, Alessandra; Gamberi, Tania*
Cellular pharmacology of gemcitabine. 2006 E. Mini; S. Nobili; B. Caciagli; I. Landini; T. Mazzei
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 2014 Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C.
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 2004 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E.
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 2004 Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 2021 Cirri, Damiano; Landini, Ida; Massai, Lara; Mini, Enrico; Maestrelli, Francesca; Messori, Luigi
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 2016 Serratrice, M; Maiore, L; Zucca, A; Stoccoro, S; Landini, I; Mini, E; Massai, L; Ferraro, G; Merlino, A; Messori, L; Cinellu, Ma
Druggable Targets in Pancreatic Adenocarcinoma 2014 Nobili S; Tassi R; Landini I; Perrone G; Napoli C; Mini E
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 2016 Di Cesare Mannelli, Lorenzo; Zanardelli, Matteo; Landini, Ida; Pacini, Alessandra; Ghelardini, Carla; Mini, Enrico; Bencini, Andrea; Valtancoli, Barbara; Failli, Paola
Emerging drugs in refractory colorectal cancer 2015 Nobili, S; Galletta, A; Brugia, M; Tassi, R; Petreni, P; Landini, I; Mini, E
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 2011 Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 2018 Mini, Enrico; Landini, Ida; Lucarini, Laura; Lapucci, Andrea; Napoli, Cristina; Perrone, Gabriele; Tassi, Renato; Masini, Emanuela; Moroni, Flavio; Nobili, Stefania
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 2010 Magherini F; Modesti A; Bini L; Puglia M; Landini I; Nobili S; Mini E; Cinellu MA; Gabbiani C; Messori L.
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 2015 Tassi, R; Perrone, G; Brugia, M; Simi, L; Petreni, P; Mori, E; Landini, I; Pazzagli, M; Mazzei, T; Mini, E; Nobili, S
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 2016 Tassi, R; Mini, E; D'Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Napoli, C; Picariello, L; Brugia, M; Landini, I; Mazzei, T; Tonelli, F; Nobili, S
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. 2010 Nobili S; Mini E; Landini I; Gabbiani C; Casini A; Messori L.
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 2012 Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 2009 Mini E; Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Mazzei T.
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 2014 Nobili S; Napoli C; Puccini B; Landini I; Perrone G; Brugia M; Benelli G; Doria M; Martelli M; Finolezzi E; Di Rocco A; Del Fava E; Rigacci L; Di Lollo S; Bosi A; Mini E.